Search Result "QSAR of HDACis"


QSAR and Docking Studies on Different Series of Histone Deacetylase Inhibitors (HDACIs)

Journal: Letters in Drug Design & Discovery
Volume: 9 Issue: 4 Year: 2012 Page: 367-378
Author(s): Yuhong Xiang, Liang Zhang, Zhuoyong Zhang

Research Article

3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 12 Issue: 4 Year: 2017 Page: 365-383
Author(s): Tooba Abdizadeh,Razieh Ghodsi,Farzin Hadizadeh

Molecular Docking and 3D-QSAR Studies on Quinolone-based HDAC Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 13 Issue: 7 Year: 2016 Page: 577-586
Author(s): Yi Bi, Zeyun Liu, Xianxuan Liu, Xiaochen Zhang, Jing Lu

3D QSAR of Aminophenyl Benzamide Derivatives as Histone Deacetylase Inhibitors

Journal: Medicinal Chemistry
Volume: 6 Issue: 5 Year: 2010 Page: 277-285
Author(s): Mahipal, Om Prakash Tanwar, C. Karthikeyan, N. S. Hari Narayana Moorthy, Piyush Trivedi

Research Article

Pharmacophore Based 3D-QSAR, Virtual Screening and Docking Studies on Novel Series of HDAC Inhibitors with Thiophen Linker as Anticancer Agents

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 19 Issue: 9 Year: 2016 Page: 735-751
Author(s): Preeti Patel,Avineesh Singh,Vijay K. Patel,Deepak K. Jain,Ravichandran Veerasamy,Harish Rajak

Review Article

Common SAR Derived from Multiple QSAR Models on Vorinostat Derivatives Targeting HDACs in Tumor Treatment

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 33 Year: 2016 Page: 5072-5078
Author(s): Sugathan Praseetha,Srinivas Bandaru,Mukesh Yadav,Anuraj Nayarisseri,Sivanpillai Sureshkumar

Quantitative Structure-Activity Relationship Study of Histone Deacetylase Inhibitors

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 4 Issue: 3 Year: 2004 Page: 273-299
Author(s): Aihua Xie, Chenzhong Liao, Zhibin Li, Zhiqiang Ning, Weiming Hu, Xianping Lu, Leming Shi, Jiaju Zhou

Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2013 Page: 1999-2013
Author(s): Li Zhang, Jine Lei, Yuanyuan Shan, Hao Yang, Maxiaowei Song, Ying Ma

Review Article

Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 6 Year: 2017 Page: 802-812
Author(s): Shuai Gao,Xiaoyang Li,Jie Zang,Wenfang Xu,Yingjie Zhang

Review Article

Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents

Journal: Current Medicinal Chemistry
Volume: 27 Issue: 15 Year: 2020 Page: 2449-2493
Author(s): Loredana Cappellacci,Diego R. Perinelli,Filippo Maggi,Mario Grifantini,Riccardo Petrelli

Previous   Next

Go To   Results 1 - 1 of 28

Apply Filters

Volume Years
Article Type
    Publication Title
    Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy